IGC Pharma
IGC
#10740
Rank
ยฃ15.54 M
Marketcap
ยฃ0.13
Share price
-4.61%
Change (1 day)
-48.40%
Change (1 year)
IGC Pharma, Inc. (formerly India Globalization Capital, Inc.) is a clinical-stage pharmaceutical company focused on developing advanced treatments for diseases, with a primary focus on Alzheimer's disease and other neurological conditions.

Earnings for IGC Pharma (IGC)

Earnings in 2026 (TTM): -ยฃ4.88 Million

According to IGC Pharma's latest financial reports the company's current earnings are ยฃ1.18 Million. In 2025 the company made an earning of -ยฃ4.05 Million, an increase over its 2024 earnings that were of -ยฃ6.67 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for IGC Pharma from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ4.88 Million20.45%
2025 -ยฃ4.05 Million-39.35%
2024 -ยฃ6.67 Million-37.72%
2023 -ยฃ10.71 Million1.19%
2022 -ยฃ10.59 Million21.96%
2021 -ยฃ8.68 Million27.13%
2020 -ยฃ6.83 Million57.16%
2019 -ยฃ4.35 Million85.47%
2018 -ยฃ2.35 Million52.76%
2017 -ยฃ1.54 Million-16.23%
2016 -ยฃ1.83 Million-28.75%
2015 -ยฃ2.57 Million-19.59%
2014 -ยฃ3.2 Million6.79%
2013 -ยฃ3 Million-9.47%
2012 -ยฃ3.31 Million-74.03%
2011 -ยฃ12.73 Million119.78%
2010 -ยฃ5.79 Million62.02%
2009 -ยฃ3.58 Million74.39%
2008 -ยฃ2.05 Million-313.12%
2007 ยฃ0.96 M-35.94%
2006 ยฃ1.5 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Sterling Infrastructure
STRL
ยฃ0.59 B-12,021.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trinity Industries
TRN
ยฃ0.55 B-11,253.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Granite Construction
GVA
-ยฃ0.12 Billion 2,142.84%๐Ÿ‡บ๐Ÿ‡ธ USA